XBI
$119.58
SPDR(R) S&P(R) Biotech ETF
ENDING SOONFirst 100 Only
Help Us Build Premium ETF Tools
4 quick questions • Get LIFETIME free access
Worth $2,400→ FREE
Explore sections
1 Month
+7.16%
YTD
+22.50%
1 Year
+22.50%
3 Year
+50.39%
Top 10 Holdings (28.7% of portfolio)
- State Street Global Advisors6.17%
- Alnylam Pharmaceuticals Inc2.66%
- Exelixis Inc2.59%
- United Therapeutics Corp2.53%
- Insmed Inc2.50%
- Gilead Sciences Inc2.47%
- Natera Inc2.47%
- Regeneron Pharmaceuticals In…2.46%
- Neurocrine Biosciences Inc2.46%
- Moderna Inc2.42%
| Rank | Company | Ticker | Sector | Weight |
|---|---|---|---|---|
| 1 | State Street Global Advisors | GVMXX | Financials | 6.17% |
| 2 | Alnylam Pharmaceuticals Inc | ALNY | Health Care | 2.66% |
| 3 | Exelixis Inc | EX9 | Health Care | 2.59% |
| 4 | United Therapeutics Corp | UTH | Health Care | 2.53% |
| 5 | Insmed Inc | IM8N | Health Care | 2.50% |
| 6 | Gilead Sciences Inc | GILD | Health Care | 2.47% |
| 7 | Natera Inc | NTRA | Health Care | 2.47% |
| 8 | Regeneron Pharmaceuticals Inc | REGN | Health Care | 2.46% |
| 9 | Neurocrine Biosciences Inc | NBIX | Health Care | 2.46% |
| 10 | Moderna Inc | MRNA | Health Care | 2.42% |
Similar ETFs(in Health Care sector)
Help Us Improve ETF Tools
Share your feedback and get early access to new features
Quick 2-minute survey→ FREE